{"ticker": {"uuid": "afe83992-07f6-4f9e-a80a-6faafb26e903", "symbol": "BIIB", "name": "Biogen Inc.", "exchange": "MEX", "country": "MX", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Guggenheim Adjusts Price Target on Biogen to $280 From $260, Maintains Buy Rating", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNVGVFVE04OUVja3JYTDk3OUoyM250Y2s0UmRXbHFzeXhkRU9hWjFKN1AxVThsMVVETjkxMWdIZTZ2YjdocUZaNVlCVDJjN0x0UHBzRURZRk5JVTJxS1pzVTdUVDhHN2hJZTA2ZmRLc3UxR0tGb3pnS01YWmlCaHN5dkIzMlNvT0FURG1ocW00X2RtRUtPZzhJWXlwdWNqajE4eUFjYmtBVFBmV1FBdWtYamFWWFc3UF9ZNG1KSy1uUUhEU0U4REQ3WGVUQQ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-21T11:10:40+00:00", "published_display": "21 Jul 2026 11:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BofA cuts Biogen stock price target on higher expectations bar", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxObkZEcVVKejh0WDVjLTNtSUVOdjJPdVFDYVhRNEFlbEJPck9EcmRzWkZwM2JxYmJZd3Q1dXQtUWxNd2lrVXBnb1Fma21FNU5ZWGpRWjlrT1JkUURKaVFvaGZtZGlpVEg5YTAwWlNtelYwZ2NJVXljRE84WmFLZW5jWGY4WXpFUm9za3FDY0JsOVFDZEQxNnJVRWNWNFlCV3Jsdm9OcFBDNDI1REI2R1RLMDlQMTJHRTRKOW5oSUJ0Zw?oc=5", "source_name": "Investing.com", "published_at": "2026-07-21T11:01:23+00:00", "published_display": "21 Jul 2026 11:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen (BIIB) Expands Its Alzheimer\u2019s Pipeline, Is The 9% Undervaluation Still There?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-21T07:22:06+00:00", "published_display": "21 Jul 2026 07:22", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lobbying Update: $1,060,000 of BIOGEN lobbying was just disclosed", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNYkRQZ18xQVR2T19GOVcyUWJDLUxzUU43N0RrTC15aDZ4UXF5eE5nbnROejVTLWdaZzdVLTFoeTVrN1FHNnlxSzZvOG15ME9OSTlBR0VCLWdXNEh3ZnBxRE9OS1VFNHExazdwRWY0c2lyWGVkSkpvV1RHc2ZWQlEtYjVNMXFvUVNtYmlZRkpSZGN4bjhIMDNsNmNKU1drVVNvNVUwTHJuUnUwdw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-21T03:07:00+00:00", "published_display": "21 Jul 2026 03:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Shares Decline After Detailed Diranersen Alzheimer's Study Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNYTFpME1vOFgzcnlUelhWbjB4VE1XOURJVnEyNXlOYkZvM0tQdGlkQXpOYTA2MXVtV01vMXZ1UUFvWUg4MFl4Z2ozQUtVc2xjaVJqSGFWYUdrWklkSEhLUzlWOVNpay1XREZDRktjNGZ0dlhDWGNkekFMTmxwV09wVzMzQTZ5RW41VldzOWgtaWpGSVhnaUVTMnlqSmM2NF85czl6NQ?oc=5", "source_name": "Market source", "published_at": "2026-07-15T14:51:00+00:00", "published_display": "15 Jul 2026 14:51", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AAIC26: Biogen stock drops after unveiling tau-targeting ASO data", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPQWRsTVNULWt1Y2Q0RVFPNmktOFFFLXhiYkdyeGJLeTBMcDhwMVViMnNjbWFzbF9Yc3lfTnVnVENFeVc4cjNzSmhYMTVsX1lTcFoyNTNVd19YY1BKZDRZSlVJOXdtVEs1dVBSNFY2aUR4R21nY0ZIT0k5a1MzTmIxM0dHbWxTMGRsVmdvWVBkVjhSdE5kbU93UDRuWl9BZXBBNS0tLXdOTHNtdw?oc=5", "source_name": "Clinical Trials Arena", "published_at": "2026-07-15T10:38:07+00:00", "published_display": "15 Jul 2026 10:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen (BIIB) Following Fresh Alzheimer\u2019s Data Is The Upside Story Still Intact", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxONk5GX0ZoNHhUVFNpb0hlRmEyRHY1UC1xUjl2ZFBidUxKNW1zTTRJckdsbzlDMU5VNlNkcHdKM19KcURzMzRDZzU1enJTcEo2ckJRTjhpSERaVmlVWmFYeWlOWVBFSXU5ZFFoSHBCZzhlLXNqYmNKUVBqN2cyQWx1RmdaZmJ3dWhFU3NoZUFfeVFYek5IM3NTS0cxaTRtaGphTl9BVw?oc=5", "source_name": "Market source", "published_at": "2026-07-15T02:11:00+00:00", "published_display": "15 Jul 2026 02:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen defends anti-tau drug after stock slides on Alzheimer\u2019s readout", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNSW45Q216RDR0VU1LTmgzRXF2M1BEdVExcGZhVDBDWlQzNHVVLXpNYmRtRHFGZkJPZGJxc3gzQkpQSzE1eldnUE5xdGUyMkE4RkxvdEl6aHBfNFMweUV5RTI5OWNzcHNzQUNWNGJLaTRyZllYblBJQmQtZzUzVzh3YWF5Ry1xSjV5azhfNmhoREdVdk8wRk8zaFZTZTZIRUk2Mm5IeUYyYw?oc=5", "source_name": "Fierce Biotech", "published_at": "2026-07-14T18:00:18+00:00", "published_display": "14 Jul 2026 18:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here is Why Biogen (BIIB) is One of the Most Undervalued NASDAQ Stocks to Buy Right Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNR1huQlhQV3dTUFFGeXMxMFBOVkc3aXhaYUhscUhUdE9UQTRSVk9CNGtDRGFhcTQyYlowbXdiNUR2RGdDczNMZXdwblR5OFdNNk04cjRLUkR3cXN4MXhKVG1RWXYtT1NTb2V6d2JiMzF6dndGX194alkwZGw4UjdubUxkWXpuM0E1MEZIVXo3SlFvWlE?oc=5", "source_name": "Market source", "published_at": "2026-07-05T07:00:00+00:00", "published_display": "05 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQMkdWZWNjRG00OWpVUDg2eGdTUUQ5aUw0TlVzY2kyV1I3Ykdfa0VycVJjQ3VYU01KXzBHa0QyY1VKNmdWNm83RDdVQ1FVcEVRS0hqb2FOVzJTb01qc3ZjYk5UczNxX0doYnhrOHdfMEt1eHZna1lpZ0FTSUhpLWZLNXZJNU45dUNSRThVcEllMzRpU2NtLVlr?oc=5", "source_name": "Market source", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Biogen (BIIB) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPbmNGeFAtenBxazFmYWJoYzFSd2tSRDRHa3J2S1F6SVdKRkFxTzY1WlFxeFg0TV9VYzBBdk54MmtBUFhNY211enhVSGUxeTczMURlUEktTmVpLUVDUUFDRzNBT2pWUFdVRUlCT3U0VHVfYjMxZUs1bW4xeWJTU2hXUURrTG9EaGdnbGU4N0hJNHVxb3l5UUFn?oc=5", "source_name": "Market source", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen (BIIB) Stock Could Be 10.3% Undervalued on Its Pipeline Narrative", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNdVlTVFE5VWtlZDZCV1lvVU5sMzV5QUc1UW8tMEFITTR6SkxKZmpSYjVWaXpaeHNNLXJFcXVpeGpiVXhOZXBHQlZVZlNJMXR1UFFLYW9mUG9jajJUZXE4cWhybGZ6Nm1DZ0x2ZVFEb0d2eFByWTl5VUZicTN4SVlhVWdpdmNGZE5WYXRqRDYwU3FUWUdReXc?oc=5", "source_name": "Market source", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNYzAtRGZ1NXQxMGFYMy1CdElVRHRTMjhjajJlX2U4WmxjMzhneWRVb2hfSkpxNDJ2emRqYTE1MmlDQ2p0VzlwV1Z3a1htbVhXRzlleTB3VFlMR21yZ2hrT0t0YmE3Z19sMWFCQTNRUlBodGRWZzZKTHFndUFMdzBtb0taakYtVFJlSE9EczhwYWNlUzAtMERMR19HN2c1SnpSQ2w0YnhBUDVXdTJXXzZHU3RXb1FTYzJuUDRDbm15ejVfUVlVYzRjNnZzRmczenBqcUhhR2lDMm9QN3p4aWxtb25JRXNEMXpZ?oc=5", "source_name": "PR Newswire", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Acquisition of Apellis Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOZ256enZtNjcySFlVRFVBdlVmVlIxLVFUYVZGVVJCMWJyaEVwaG1XSFdrOWxZU3ZDWGtiZmVUNkRtSmtKeTIyaldoQ2xuQ3JzaXdQeUNteGZOM3hZYzI5UUJ0MXVYNDBjVGZrSldQQUFSaF9MUUphR1lyX3daMl9pODJkdGU1NWRLM0NLRDlvelJmOEkzYV92VkY1TE1qWEFXV3dyWW1FeGJObnowT0VfUlRISFR0YXc?oc=5", "source_name": "Biogen", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen (BIIB) Stock Trades Up, Here Is Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNek03UkJPMmJFMlJJV1VxeGMwcjRFamV2T251SEdnVGhUbXlCWldWSnBYUU0tNDdGdkxPVVhsX0RYdkpNUnZYcEtJLVk1U244aE5JMHVTMGJ0TURINWtxcEotYUkteXc4RjVoRnZwNmNRYVBodjFZZ3ZxS0hybE1XMHhMaUhyekR0RlY4SzdQQnJ1ODJUY21xVQ?oc=5", "source_name": "Market source", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here Are Tuesday\u2019s Top Wall Street Analyst Research Calls: Biogen, Birkenstock, Fastly, Ford, Lennox International, Netskope, SanDisk, Tesla, and More", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgJBVV95cUxOZDIzTjBpdWpFNjRJQ3V1a3FaVHpVTUlSZW9YVXloRGc4Q1J1Mnp0UGd3UEsxN1JudGx6QUFZQkJhVmRTSk9IVnpYQk1JUXZLSFVGeWlIS1pkSW1jRDd3a2RwemJCb09BMGRGbHNnNDctcy1SWDdTc3JQWGRQS1RlOE5WZHdfMDRoeGxTbzBwX2lNSkY2S2h2NjJBOUZmc3ZfQ29rR1g1OHQ2aHVHeVNCMEdJMG0tUmNKQ1V1NDBiYWdWcVY4THJiRHRQNElwSFFFS2JMWkFyczVRNEZWSmVpQXZrSm1iM1VpaktFdVFGeHh4OGRwTWdkTVc3Qk5Ea1JMQUQ4ZWFic21CT01SNmxEUUJ3?oc=5", "source_name": "24/7 Wall St.", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Acquire Apellis, Enhancing the Company\u2019s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOVEV0VlhLbzVMaGdWYjJJLVN4V0NIVnVidDk2NW9vRzVpTTNwVDBZTl9aQW9Xd0FKQ3JTeXBvcUZpSTFQNHEwN3NRX1FTeUdfdVNlYWpDZlREb1lOd0RVemRNUG5WRnlHN3R1czVXN2NteVFqeV9hYzZybXZZWVkwTDZSNlFrQmJtNFBOUjZqZU9jRXFRRmFhNE1oNkVfM1ZrWEFIZ2FQclpuYmRYV09jVDdGSDZKZ1BPYnhXZHNIZw?oc=5", "source_name": "Biogen", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Buy Apellis for $5.6 Billion to Boost Kidney Franchise", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOa1pUNWRyWTFWMl9sRk9GTDhkNW5YWVZQRWQ2enRTbGpIb0JxZzlxUDBNdE9QTmtJMHpVeFBNZnN0SHNmQmNqdUxseFB4QkMzRTY2Q1pnMFIwV0hpdDFmTDFEUXlIalZhYTZfSmlqODU2b0I2UjNNcVRtdFN0ZDVpdGVTblZPUzdVdWhTOEJTR19XWmdlSFA1VzNiLUFTU3NtNTRfVEZXbWFFbmxwWFhwZjl4SGo?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Share New SMA Data at Muscular Dystrophy Association and SMA Europe Conferences", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNRWZUUFdGSnJzeUhKM19mMGtuODF6NW11UTNfYTV2amdxT25zR1VQWlIyLVhtTUswV1VOWDR4cUNPRUFPdkJvOGo0cWxRUjBNN2NOaDg2Nk9UYlRseUVwWnkwWmpnNUFsMUVhOXYtcEtGRHM5MlJOVjhTYnJRX1NuQWxTX282ZDQ4Q0t2TVJJbTFYZ09fT2NYeG5pUVZiVzVLS2xwMldxWnBjTVFEZnF4aTlna0lMbUJ1N1FLWHRRYXhaalNNel93?oc=5", "source_name": "Biogen", "published_at": "2026-03-05T12:32:19+00:00", "published_display": "05 Mar 2026 12:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Acquisition of Alcyone Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNOGRybmhqVmpTUUxzQ2xtbEllRDNCdjdyREVVbjdyUEp1XzFaVl9zaFN2TUV2b1YtQXZLY0p2Ulc0eG9BaE9ZdDJ3SlJFVUczMzJMYXZFRHlmMlF1cG42V1RIY0ZLNmI4N2pIVFRLc2VLSGxrX0JVNGVybF9XRV9ZZFdMZXMtS3JNNGh4X3FqdDFqUUxLSWkzYTJiZFh0T3ItaTMxWGRmV0JSSUpKcWxoYjhnbw?oc=5", "source_name": "Biogen", "published_at": "2025-11-14T08:00:00+00:00", "published_display": "14 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNVUxBUmhVNXg4eEJUeXFYeW0yMjNDSWxRSktnMzRjTldpbHVWYm1Oa3pFZUthbmtzWi1mZDFaY1dzWXhFQ3RQZkc2TWNTLTMxd1hEZmQ5MlBNWHl2ZzhINHdIanE1c2RxZi0yTEdxd2NRUUJjSms3bDF2WXpTUllPN3p5T3MwOWZKcGpFdkZ3MEpCUTdyeHRQUG9lYk1wWFVmTnJBYWNNTTNOVUE5MXZnYVNNc21lVXFBM2dqeTB4SDdEeUU?oc=5", "source_name": "Biogen", "published_at": "2025-02-18T08:00:00+00:00", "published_display": "18 Feb 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Acquisition of Reata Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNQUJPYXk0Y3dERjAxRVRmYVdvV1ZOSVRTYXI2eTgxOVVRWjdPUlNnZy1UanR3MldJN1d3TVEwOFR4SWkwaEJRZmpoOGtSN09iMmdvYjZkSk4zRVJBQXFNaFdOeG5QWm8yLVlhOEVpQmRiaHY5WkJ2akx6d0FFaVZKelZKT3ZIM2hibzNGWkNiQXcxWlAzci1nN2hOdnQ4dC1JNDNsRzktZEFQUW9PdmVBakM3SlA?oc=5", "source_name": "Biogen", "published_at": "2023-09-26T07:00:00+00:00", "published_display": "26 Sep 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Acquire Reata Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPLW5Vbmd0c1FZbTd4MzduTnlKa19DS0tNRzlBRjlxMGhqdlhkNm5XUGFTcExGS2JDcHQyTmtQNk5OOGFIYkF5RFFwbXNOSWhRNmh2eW44TzhBNXdRZlVLOUZrb2p6c0VDQ2hqQzZvbUlQOFVCejRsNEd3MXpmQVlMcExFT3NtdnB1cFJjZDRBdTEwa2Y5c1ZLTURlczJFbVJaQVE?oc=5", "source_name": "Biogen", "published_at": "2023-07-28T07:00:00+00:00", "published_display": "28 Jul 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Stock Trading Halted Today; FDA Advisory Committee to Review Supplemental Biologics License Application for the Potential Traditional Approval of LEQEMBI in Early Alzheimer\u2019s Disease", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQTUlIb3NucjNtT2VWMkdlUWJPS2I5cDdGVk00LVNJaUxmcTdBd3dFU0VmeENPMlhDdzZWYWwxSGlOQXNpd3QtLVlpNW1jcFlyR1pVekRkLTdyT2VLX1BrdmRRdncxNXRsM0QxVWxyb3RldlZZMm1YTUpaVndtbWtITjBmRU9ZOGRtaG5SSUQwYjRpR0RUQjU2NWZDQmdMZFk1MEVRUnVqclQ2TTdLTnFXT3htODNEQmx2bjhaTHNvMWxuS002SXc?oc=5", "source_name": "Biogen", "published_at": "2023-06-09T07:00:00+00:00", "published_display": "09 Jun 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen and Sage Therapeutics Share Update on FDA Advisory Committee for Zuranolone", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPZF80SWRrOUpTTHZYdmlMTWtxNEJ6SzVDVXc0MjV2RUlRQkhuRHpiV3VZel9haElzVGNEdG81d05jaVZCMlFnbkFhS1hzeHQxejRWTG50RHBJSVptc3F3NnBtLVQxNkE4d1paM3B2T2t5a2thNlVWUTVOUkdBSEw3ai1TUlBJaExURm1la2hvVWxnTkw5R242ekxTdDBwdjJCR1JfcHdkR05PS2w1Y250T3lhUlBtMHF5UUg5aFNmZVl4Z0ROQnlB?oc=5", "source_name": "Biogen", "published_at": "2023-03-08T08:00:00+00:00", "published_display": "08 Mar 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Reaches Agreement with Samsung Biologics to Sell Equity Stake in Their Biosimilar Joint Venture for up to $2.3 billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOX01BMWpxUHpWYmFRQTN3U016ZEhjUFQ1UmdDeVR6MHJER0VvNnZIMkw1TXhuWjRaX1JqamxZeFVqeDk1QWgyamFsdUhBb2VpMmhUeWVyQmRIYVNkR2ZOLUpCYU83RXh2U0hhMkhYZy1vS21LSVJncllnZjVXSHd6Mm1EVGZOUDhpNkhveHFyLTZqNHlZYmwtVXBJYWRJQmFnaHdxcW9ZVUFqX3pNSFlBY3RhQVdrZ1pybnNHYUktNUZJQQ?oc=5", "source_name": "Biogen", "published_at": "2022-01-27T08:00:00+00:00", "published_display": "27 Jan 2022 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQQUlSWmZWUV9mYktRV081cXN6c1BRVmxjbXRRSEQ1MTd2SnlCZERDNVFXZGtnQlpMb3B0MHJqRzYtcjVROEczRGRtQUZMMm56TFlQdFVNWnpwVEFuUm9CU1MyUlJvcGR5dHdPQUdjVWIwQmd5d1A3TXQ3dlNabXN2U2VkSGZJMWx2bUt4RHhkWnRPc1ZPeDYydEtlOUplZUg4SEhNd3N5WWk3eXc3M0YtcVl5WHlrM3pOZFN2dHkwaw?oc=5", "source_name": "Biogen", "published_at": "2020-11-27T08:00:00+00:00", "published_display": "27 Nov 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen\u2019s Board of Directors Approves Separation of Bioverativ and Declares Special Dividend Distribution of Bioverativ Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNZXh4dlJwdnhYS3pNay02VWZaYXNqbm1Lamx2NFIxbVhPelI3WVNzeVJJa3RJZU45UllHYUhjMGtqcmgyMUZzZ0pkRzJlVFlOTTl2WVNzcjVfb3JGcnAyWWpSODg4dFUyMmthZU1xMGdJWlAxRWhISzgtZDVIaGRRc1Q0cHhBeHJJYVJURThvQlV0RV8yWmh4QjluN3ZEZnNNeXhvR3BScy1kSnR5UmN0Vk93S3ljek5scmY2ZkV5TQ?oc=5", "source_name": "Biogen", "published_at": "2019-06-12T10:45:37+00:00", "published_display": "12 Jun 2019 10:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Guggenheim Adjusts Price Target on Biogen to $280 From $260, Maintains Buy Rating", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNVGVFVE04OUVja3JYTDk3OUoyM250Y2s0UmRXbHFzeXhkRU9hWjFKN1AxVThsMVVETjkxMWdIZTZ2YjdocUZaNVlCVDJjN0x0UHBzRURZRk5JVTJxS1pzVTdUVDhHN2hJZTA2ZmRLc3UxR0tGb3pnS01YWmlCaHN5dkIzMlNvT0FURG1ocW00X2RtRUtPZzhJWXlwdWNqajE4eUFjYmtBVFBmV1FBdWtYamFWWFc3UF9ZNG1KSy1uUUhEU0U4REQ3WGVUQQ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-21T11:10:40+00:00", "published_display": "21 Jul 2026 11:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BofA cuts Biogen stock price target on higher expectations bar", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxObkZEcVVKejh0WDVjLTNtSUVOdjJPdVFDYVhRNEFlbEJPck9EcmRzWkZwM2JxYmJZd3Q1dXQtUWxNd2lrVXBnb1Fma21FNU5ZWGpRWjlrT1JkUURKaVFvaGZtZGlpVEg5YTAwWlNtelYwZ2NJVXljRE84WmFLZW5jWGY4WXpFUm9za3FDY0JsOVFDZEQxNnJVRWNWNFlCV3Jsdm9OcFBDNDI1REI2R1RLMDlQMTJHRTRKOW5oSUJ0Zw?oc=5", "source_name": "Investing.com", "published_at": "2026-07-21T11:01:23+00:00", "published_display": "21 Jul 2026 11:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen (BIIB) Expands Its Alzheimer\u2019s Pipeline, Is The 9% Undervaluation Still There?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-21T07:22:06+00:00", "published_display": "21 Jul 2026 07:22", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lobbying Update: $1,060,000 of BIOGEN lobbying was just disclosed", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNYkRQZ18xQVR2T19GOVcyUWJDLUxzUU43N0RrTC15aDZ4UXF5eE5nbnROejVTLWdaZzdVLTFoeTVrN1FHNnlxSzZvOG15ME9OSTlBR0VCLWdXNEh3ZnBxRE9OS1VFNHExazdwRWY0c2lyWGVkSkpvV1RHc2ZWQlEtYjVNMXFvUVNtYmlZRkpSZGN4bjhIMDNsNmNKU1drVVNvNVUwTHJuUnUwdw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-21T03:07:00+00:00", "published_display": "21 Jul 2026 03:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Shares Decline After Detailed Diranersen Alzheimer's Study Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNYTFpME1vOFgzcnlUelhWbjB4VE1XOURJVnEyNXlOYkZvM0tQdGlkQXpOYTA2MXVtV01vMXZ1UUFvWUg4MFl4Z2ozQUtVc2xjaVJqSGFWYUdrWklkSEhLUzlWOVNpay1XREZDRktjNGZ0dlhDWGNkekFMTmxwV09wVzMzQTZ5RW41VldzOWgtaWpGSVhnaUVTMnlqSmM2NF85czl6NQ?oc=5", "source_name": "Market source", "published_at": "2026-07-15T14:51:00+00:00", "published_display": "15 Jul 2026 14:51", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AAIC26: Biogen stock drops after unveiling tau-targeting ASO data", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPQWRsTVNULWt1Y2Q0RVFPNmktOFFFLXhiYkdyeGJLeTBMcDhwMVViMnNjbWFzbF9Yc3lfTnVnVENFeVc4cjNzSmhYMTVsX1lTcFoyNTNVd19YY1BKZDRZSlVJOXdtVEs1dVBSNFY2aUR4R21nY0ZIT0k5a1MzTmIxM0dHbWxTMGRsVmdvWVBkVjhSdE5kbU93UDRuWl9BZXBBNS0tLXdOTHNtdw?oc=5", "source_name": "Clinical Trials Arena", "published_at": "2026-07-15T10:38:07+00:00", "published_display": "15 Jul 2026 10:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen (BIIB) Following Fresh Alzheimer\u2019s Data Is The Upside Story Still Intact", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxONk5GX0ZoNHhUVFNpb0hlRmEyRHY1UC1xUjl2ZFBidUxKNW1zTTRJckdsbzlDMU5VNlNkcHdKM19KcURzMzRDZzU1enJTcEo2ckJRTjhpSERaVmlVWmFYeWlOWVBFSXU5ZFFoSHBCZzhlLXNqYmNKUVBqN2cyQWx1RmdaZmJ3dWhFU3NoZUFfeVFYek5IM3NTS0cxaTRtaGphTl9BVw?oc=5", "source_name": "Market source", "published_at": "2026-07-15T02:11:00+00:00", "published_display": "15 Jul 2026 02:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen defends anti-tau drug after stock slides on Alzheimer\u2019s readout", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNSW45Q216RDR0VU1LTmgzRXF2M1BEdVExcGZhVDBDWlQzNHVVLXpNYmRtRHFGZkJPZGJxc3gzQkpQSzE1eldnUE5xdGUyMkE4RkxvdEl6aHBfNFMweUV5RTI5OWNzcHNzQUNWNGJLaTRyZllYblBJQmQtZzUzVzh3YWF5Ry1xSjV5azhfNmhoREdVdk8wRk8zaFZTZTZIRUk2Mm5IeUYyYw?oc=5", "source_name": "Fierce Biotech", "published_at": "2026-07-14T18:00:18+00:00", "published_display": "14 Jul 2026 18:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here is Why Biogen (BIIB) is One of the Most Undervalued NASDAQ Stocks to Buy Right Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNR1huQlhQV3dTUFFGeXMxMFBOVkc3aXhaYUhscUhUdE9UQTRSVk9CNGtDRGFhcTQyYlowbXdiNUR2RGdDczNMZXdwblR5OFdNNk04cjRLUkR3cXN4MXhKVG1RWXYtT1NTb2V6d2JiMzF6dndGX194alkwZGw4UjdubUxkWXpuM0E1MEZIVXo3SlFvWlE?oc=5", "source_name": "Market source", "published_at": "2026-07-05T07:00:00+00:00", "published_display": "05 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQMkdWZWNjRG00OWpVUDg2eGdTUUQ5aUw0TlVzY2kyV1I3Ykdfa0VycVJjQ3VYU01KXzBHa0QyY1VKNmdWNm83RDdVQ1FVcEVRS0hqb2FOVzJTb01qc3ZjYk5UczNxX0doYnhrOHdfMEt1eHZna1lpZ0FTSUhpLWZLNXZJNU45dUNSRThVcEllMzRpU2NtLVlr?oc=5", "source_name": "Market source", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Biogen (BIIB) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPbmNGeFAtenBxazFmYWJoYzFSd2tSRDRHa3J2S1F6SVdKRkFxTzY1WlFxeFg0TV9VYzBBdk54MmtBUFhNY211enhVSGUxeTczMURlUEktTmVpLUVDUUFDRzNBT2pWUFdVRUlCT3U0VHVfYjMxZUs1bW4xeWJTU2hXUURrTG9EaGdnbGU4N0hJNHVxb3l5UUFn?oc=5", "source_name": "Market source", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen (BIIB) Stock Could Be 10.3% Undervalued on Its Pipeline Narrative", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNdVlTVFE5VWtlZDZCV1lvVU5sMzV5QUc1UW8tMEFITTR6SkxKZmpSYjVWaXpaeHNNLXJFcXVpeGpiVXhOZXBHQlZVZlNJMXR1UFFLYW9mUG9jajJUZXE4cWhybGZ6Nm1DZ0x2ZVFEb0d2eFByWTl5VUZicTN4SVlhVWdpdmNGZE5WYXRqRDYwU3FUWUdReXc?oc=5", "source_name": "Market source", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNYzAtRGZ1NXQxMGFYMy1CdElVRHRTMjhjajJlX2U4WmxjMzhneWRVb2hfSkpxNDJ2emRqYTE1MmlDQ2p0VzlwV1Z3a1htbVhXRzlleTB3VFlMR21yZ2hrT0t0YmE3Z19sMWFCQTNRUlBodGRWZzZKTHFndUFMdzBtb0taakYtVFJlSE9EczhwYWNlUzAtMERMR19HN2c1SnpSQ2w0YnhBUDVXdTJXXzZHU3RXb1FTYzJuUDRDbm15ejVfUVlVYzRjNnZzRmczenBqcUhhR2lDMm9QN3p4aWxtb25JRXNEMXpZ?oc=5", "source_name": "PR Newswire", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Acquisition of Apellis Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOZ256enZtNjcySFlVRFVBdlVmVlIxLVFUYVZGVVJCMWJyaEVwaG1XSFdrOWxZU3ZDWGtiZmVUNkRtSmtKeTIyaldoQ2xuQ3JzaXdQeUNteGZOM3hZYzI5UUJ0MXVYNDBjVGZrSldQQUFSaF9MUUphR1lyX3daMl9pODJkdGU1NWRLM0NLRDlvelJmOEkzYV92VkY1TE1qWEFXV3dyWW1FeGJObnowT0VfUlRISFR0YXc?oc=5", "source_name": "Biogen", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen (BIIB) Stock Trades Up, Here Is Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNek03UkJPMmJFMlJJV1VxeGMwcjRFamV2T251SEdnVGhUbXlCWldWSnBYUU0tNDdGdkxPVVhsX0RYdkpNUnZYcEtJLVk1U244aE5JMHVTMGJ0TURINWtxcEotYUkteXc4RjVoRnZwNmNRYVBodjFZZ3ZxS0hybE1XMHhMaUhyekR0RlY4SzdQQnJ1ODJUY21xVQ?oc=5", "source_name": "Market source", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here Are Tuesday\u2019s Top Wall Street Analyst Research Calls: Biogen, Birkenstock, Fastly, Ford, Lennox International, Netskope, SanDisk, Tesla, and More", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgJBVV95cUxOZDIzTjBpdWpFNjRJQ3V1a3FaVHpVTUlSZW9YVXloRGc4Q1J1Mnp0UGd3UEsxN1JudGx6QUFZQkJhVmRTSk9IVnpYQk1JUXZLSFVGeWlIS1pkSW1jRDd3a2RwemJCb09BMGRGbHNnNDctcy1SWDdTc3JQWGRQS1RlOE5WZHdfMDRoeGxTbzBwX2lNSkY2S2h2NjJBOUZmc3ZfQ29rR1g1OHQ2aHVHeVNCMEdJMG0tUmNKQ1V1NDBiYWdWcVY4THJiRHRQNElwSFFFS2JMWkFyczVRNEZWSmVpQXZrSm1iM1VpaktFdVFGeHh4OGRwTWdkTVc3Qk5Ea1JMQUQ4ZWFic21CT01SNmxEUUJ3?oc=5", "source_name": "24/7 Wall St.", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Acquire Apellis, Enhancing the Company\u2019s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOVEV0VlhLbzVMaGdWYjJJLVN4V0NIVnVidDk2NW9vRzVpTTNwVDBZTl9aQW9Xd0FKQ3JTeXBvcUZpSTFQNHEwN3NRX1FTeUdfdVNlYWpDZlREb1lOd0RVemRNUG5WRnlHN3R1czVXN2NteVFqeV9hYzZybXZZWVkwTDZSNlFrQmJtNFBOUjZqZU9jRXFRRmFhNE1oNkVfM1ZrWEFIZ2FQclpuYmRYV09jVDdGSDZKZ1BPYnhXZHNIZw?oc=5", "source_name": "Biogen", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Buy Apellis for $5.6 Billion to Boost Kidney Franchise", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOa1pUNWRyWTFWMl9sRk9GTDhkNW5YWVZQRWQ2enRTbGpIb0JxZzlxUDBNdE9QTmtJMHpVeFBNZnN0SHNmQmNqdUxseFB4QkMzRTY2Q1pnMFIwV0hpdDFmTDFEUXlIalZhYTZfSmlqODU2b0I2UjNNcVRtdFN0ZDVpdGVTblZPUzdVdWhTOEJTR19XWmdlSFA1VzNiLUFTU3NtNTRfVEZXbWFFbmxwWFhwZjl4SGo?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Share New SMA Data at Muscular Dystrophy Association and SMA Europe Conferences", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNRWZUUFdGSnJzeUhKM19mMGtuODF6NW11UTNfYTV2amdxT25zR1VQWlIyLVhtTUswV1VOWDR4cUNPRUFPdkJvOGo0cWxRUjBNN2NOaDg2Nk9UYlRseUVwWnkwWmpnNUFsMUVhOXYtcEtGRHM5MlJOVjhTYnJRX1NuQWxTX282ZDQ4Q0t2TVJJbTFYZ09fT2NYeG5pUVZiVzVLS2xwMldxWnBjTVFEZnF4aTlna0lMbUJ1N1FLWHRRYXhaalNNel93?oc=5", "source_name": "Biogen", "published_at": "2026-03-05T12:32:19+00:00", "published_display": "05 Mar 2026 12:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Acquisition of Alcyone Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNOGRybmhqVmpTUUxzQ2xtbEllRDNCdjdyREVVbjdyUEp1XzFaVl9zaFN2TUV2b1YtQXZLY0p2Ulc0eG9BaE9ZdDJ3SlJFVUczMzJMYXZFRHlmMlF1cG42V1RIY0ZLNmI4N2pIVFRLc2VLSGxrX0JVNGVybF9XRV9ZZFdMZXMtS3JNNGh4X3FqdDFqUUxLSWkzYTJiZFh0T3ItaTMxWGRmV0JSSUpKcWxoYjhnbw?oc=5", "source_name": "Biogen", "published_at": "2025-11-14T08:00:00+00:00", "published_display": "14 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNVUxBUmhVNXg4eEJUeXFYeW0yMjNDSWxRSktnMzRjTldpbHVWYm1Oa3pFZUthbmtzWi1mZDFaY1dzWXhFQ3RQZkc2TWNTLTMxd1hEZmQ5MlBNWHl2ZzhINHdIanE1c2RxZi0yTEdxd2NRUUJjSms3bDF2WXpTUllPN3p5T3MwOWZKcGpFdkZ3MEpCUTdyeHRQUG9lYk1wWFVmTnJBYWNNTTNOVUE5MXZnYVNNc21lVXFBM2dqeTB4SDdEeUU?oc=5", "source_name": "Biogen", "published_at": "2025-02-18T08:00:00+00:00", "published_display": "18 Feb 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Acquisition of Reata Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNQUJPYXk0Y3dERjAxRVRmYVdvV1ZOSVRTYXI2eTgxOVVRWjdPUlNnZy1UanR3MldJN1d3TVEwOFR4SWkwaEJRZmpoOGtSN09iMmdvYjZkSk4zRVJBQXFNaFdOeG5QWm8yLVlhOEVpQmRiaHY5WkJ2akx6d0FFaVZKelZKT3ZIM2hibzNGWkNiQXcxWlAzci1nN2hOdnQ4dC1JNDNsRzktZEFQUW9PdmVBakM3SlA?oc=5", "source_name": "Biogen", "published_at": "2023-09-26T07:00:00+00:00", "published_display": "26 Sep 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Acquire Reata Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPLW5Vbmd0c1FZbTd4MzduTnlKa19DS0tNRzlBRjlxMGhqdlhkNm5XUGFTcExGS2JDcHQyTmtQNk5OOGFIYkF5RFFwbXNOSWhRNmh2eW44TzhBNXdRZlVLOUZrb2p6c0VDQ2hqQzZvbUlQOFVCejRsNEd3MXpmQVlMcExFT3NtdnB1cFJjZDRBdTEwa2Y5c1ZLTURlczJFbVJaQVE?oc=5", "source_name": "Biogen", "published_at": "2023-07-28T07:00:00+00:00", "published_display": "28 Jul 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Stock Trading Halted Today; FDA Advisory Committee to Review Supplemental Biologics License Application for the Potential Traditional Approval of LEQEMBI in Early Alzheimer\u2019s Disease", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQTUlIb3NucjNtT2VWMkdlUWJPS2I5cDdGVk00LVNJaUxmcTdBd3dFU0VmeENPMlhDdzZWYWwxSGlOQXNpd3QtLVlpNW1jcFlyR1pVekRkLTdyT2VLX1BrdmRRdncxNXRsM0QxVWxyb3RldlZZMm1YTUpaVndtbWtITjBmRU9ZOGRtaG5SSUQwYjRpR0RUQjU2NWZDQmdMZFk1MEVRUnVqclQ2TTdLTnFXT3htODNEQmx2bjhaTHNvMWxuS002SXc?oc=5", "source_name": "Biogen", "published_at": "2023-06-09T07:00:00+00:00", "published_display": "09 Jun 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen and Sage Therapeutics Share Update on FDA Advisory Committee for Zuranolone", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPZF80SWRrOUpTTHZYdmlMTWtxNEJ6SzVDVXc0MjV2RUlRQkhuRHpiV3VZel9haElzVGNEdG81d05jaVZCMlFnbkFhS1hzeHQxejRWTG50RHBJSVptc3F3NnBtLVQxNkE4d1paM3B2T2t5a2thNlVWUTVOUkdBSEw3ai1TUlBJaExURm1la2hvVWxnTkw5R242ekxTdDBwdjJCR1JfcHdkR05PS2w1Y250T3lhUlBtMHF5UUg5aFNmZVl4Z0ROQnlB?oc=5", "source_name": "Biogen", "published_at": "2023-03-08T08:00:00+00:00", "published_display": "08 Mar 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Reaches Agreement with Samsung Biologics to Sell Equity Stake in Their Biosimilar Joint Venture for up to $2.3 billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOX01BMWpxUHpWYmFRQTN3U016ZEhjUFQ1UmdDeVR6MHJER0VvNnZIMkw1TXhuWjRaX1JqamxZeFVqeDk1QWgyamFsdUhBb2VpMmhUeWVyQmRIYVNkR2ZOLUpCYU83RXh2U0hhMkhYZy1vS21LSVJncllnZjVXSHd6Mm1EVGZOUDhpNkhveHFyLTZqNHlZYmwtVXBJYWRJQmFnaHdxcW9ZVUFqX3pNSFlBY3RhQVdrZ1pybnNHYUktNUZJQQ?oc=5", "source_name": "Biogen", "published_at": "2022-01-27T08:00:00+00:00", "published_display": "27 Jan 2022 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQQUlSWmZWUV9mYktRV081cXN6c1BRVmxjbXRRSEQ1MTd2SnlCZERDNVFXZGtnQlpMb3B0MHJqRzYtcjVROEczRGRtQUZMMm56TFlQdFVNWnpwVEFuUm9CU1MyUlJvcGR5dHdPQUdjVWIwQmd5d1A3TXQ3dlNabXN2U2VkSGZJMWx2bUt4RHhkWnRPc1ZPeDYydEtlOUplZUg4SEhNd3N5WWk3eXc3M0YtcVl5WHlrM3pOZFN2dHkwaw?oc=5", "source_name": "Biogen", "published_at": "2020-11-27T08:00:00+00:00", "published_display": "27 Nov 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen\u2019s Board of Directors Approves Separation of Bioverativ and Declares Special Dividend Distribution of Bioverativ Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNZXh4dlJwdnhYS3pNay02VWZaYXNqbm1Lamx2NFIxbVhPelI3WVNzeVJJa3RJZU45UllHYUhjMGtqcmgyMUZzZ0pkRzJlVFlOTTl2WVNzcjVfb3JGcnAyWWpSODg4dFUyMmthZU1xMGdJWlAxRWhISzgtZDVIaGRRc1Q0cHhBeHJJYVJURThvQlV0RV8yWmh4QjluN3ZEZnNNeXhvR3BScy1kSnR5UmN0Vk93S3ljek5scmY2ZkV5TQ?oc=5", "source_name": "Biogen", "published_at": "2019-06-12T10:45:37+00:00", "published_display": "12 Jun 2019 10:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 89, "total_relevant": 28, "sentiment_summary": {"positive": 6, "negative": 2, "neutral": 20, "score": 54, "total": 28, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 10.25, "count": 18}, {"event": "deals", "label": "Deals and strategy", "weight": 2.2, "count": 4}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 6, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 3678.0, "latest_week": "2026-07-17", "one_week_move": 5.1, "four_week_move": 10.3, "twelve_week_move": 12.0, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.838072, "market_dynamics_buy_signal": false, "relative_strength": 16.694902, "fair_value_gap": 6.8, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 28.1899, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+5.1% over one week, +10.3% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 64, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Biogen", "count": 12}, {"label": "Market source", "count": 7}, {"label": "marketscreener.com", "count": 1}, {"label": "Investing.com", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "Quiver Quantitative", "count": 1}, {"label": "Clinical Trials Arena", "count": 1}, {"label": "Fierce Biotech", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 28}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 18}, {"label": "Deals and strategy", "count": 4}, {"label": "Analyst action", "count": 3}, {"label": "Guidance", "count": 1}, {"label": "Regulatory and legal", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "28", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+5.1% over one week, +10.3% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Guggenheim Adjusts Price Target on Biogen to $280 From $260, Maintains Buy Rating"}], "updated_at": "2026-07-21T17:41:06.853603+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}